News | April 21, 2023
Top 20 global biopharma companies report 3.4% fall in market cap in Q1 2023: GlobalData
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
India's strategy against Covid was more effective than any other countries in the world
Tavaborole Topical Solution, 5% had annual sales of US $3.1 million in the United States
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
The summit encompasses multiple verticals, spanning from pharmaceuticals, biotech, life sciences, and the Healthcare sector to ensure an unbiased and comprehensive view on the future of the function.
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
Subscribe To Our Newsletter & Stay Updated
